⁦Adam R Houston⁩ discussing vaccine COVID-19 equity - I think he may know where he may be going with this given the first slide. ⁦Jason Nickerson⁩ ⁦Sarah Lazin⁩ ⁦Nathalie Des Rosiers⁩ #BordersPandemics

Canada🇨🇦has posted updated #COVID19 #vaccine administration stats.💉💪
Just 1665 #Novavax #Nuvaxovid doses administered in last 4 weeks (out of 2,110,331).
🤔Raises questions about the millions of doses already delivered... and about future production at the NRC facility?🇨🇦💉🏭

Cholera vaccine shortage impacts WHO response amidst multiple outbreaks.
Meanwhile, even as #Schancol is being discontinued, #Vaxchora , the FDA-approved #cholera vaccine for travellers (that recycled its way to a #PriorityReviewVoucher ) is also not currently being manufactured.

MSF is warning that the health and humanitarian situation in Haiti is continuing to deteriorate.
We are admitting more than 100 patients per day to our cholera treatment centres.
Hospitals are not functioning. Women can't access lifesaving obstetric care.
msf.org/haiti-verge-he…

Good this is finally happening... but why on earth did it take so long to get from these previous steps to actually conducting a consultation? Can't blame 2018/2019 on COVID...

Pfizer Inc expects to raise the price of its COVID-19 vaccine to about $110 to $130 per dose after the United States government's current purchase program expires, Pfizer executive Angela Lukin said on a call with analysts on Thursday. reut.rs/3DctqF0

This #toxoplasmosis piece is... odd. Another interesting question for Health Canada researchers to answer would be why key drugs to treat it - at least those considered #EssentialMedicines for this indication by the WHO - are no longer formally available in Canada.
🇨🇦💊

#TBT to back when the #NRC was going to spend $15 million to upgrade their preexisting facility to produce up to 100 million doses of #COVID19 #vaccine within 6 months of a suitable candidate.

Doing some last minute conference prep/archeological digging through what now amounts to years of news reports on Canada, COVAX & vaccine hoarding, and being reminded how much good work on this topic has come from the likes of Geoffrey York Alex Boyd Mia Rabson👍.
🇨🇦💉🌐

As an aside, I hadn't realized that before it was recycled for FDA approval and a Priority Review Voucher as Vaxchora, an earlier iteration of this particular #cholera vaccine was being sold in Canada as Mutacol (until it was discontinued).
🇨🇦💉

Today in Max Bell School of Public Policy’s The Bell Newsletter, I write about Canada’s problem with clinical trial transparency.

What’s the problem, and why should you care?

A short thread 🧵

open.substack.com/pub/maxpolicy/…

Cholera vaccine shortage impacts WHO response amidst multiple outbreaks.
Meanwhile, even as #Schancol is being discontinued, #Vaxchora , the FDA-approved #cholera vaccine for travellers (that recycled its way to a #PriorityReviewVoucher ) is also not currently being manufactured.

Great to see #LassaFever vaccines in clinical trials. Reminder: this particular💉was developed by the Public Health Agency of Canada, but🇨🇦lacks a lab-to-patient pathway absent commercial interest.
Now if only the #EbolaSudan 💉in the same licensing deal was similarly progressing.

🤔'Why Was a Lyme Disease Vaccine Tossed Away? It was pulled from the market almost immediately after it was developed in 1998. Twenty-five years later, the painful disease is on the rise' thewalrus.ca/lyme-disease-v…

Interesting update on the #Medicago #Covifenz vaccine. Still curious if scale-up challenges are financial/technical etc.🇨🇦💉
(also still curious what WHO would have done if this were the only, or clearly the best, #COVID19 vaccine. Or if #ZMapp were the answer for #Ebola ...).

“It's important for governments to attach access conditions to funding R&D initiatives by the private sector to ensure public benefit”- MSF Access Campaign’s Candice Sehoma, today, on the #mRNA Tech Transfer Hub’s sustainability at the World Health Summit (2022) 🌍⛰ #WHS2022

Zimbabwe is the first county in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention who.int/news/item/17-1… World Health Organization (WHO) UNAIDS Unitaid Meg Doherty World Health Organization (WHO)AFRO Γιάννης Μαμελετζής (він/його) 🇺🇦🕊💐🦠🧬 🎾 MedicinesPatentPool

COVAX did not fail because it was badly designed says Mike Ryan at #WHS2022 :
'We failed because of the greed of the north. We failed because of the greed of the pharmaceutical industry. We failed because of self-interest in certain member states, who were not prepared to share'